ArticleBMC pregnancy and childbirth2025
Women's intention and factors associated with duration of use of Iron-folic acid supplement use in Karu, Nasarawa State, Nigeria: A cross-sectional study.
Article in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Modifiable risk factors for anemia in pregnancy: an umbrella review of systematic reviews and meta-analyses.BMC pregnancy and childbirth · 2025Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIron-folic acid supplementation is one of the key interventions provided during antenatal care (ANC) services to reduce iron deficiency, maternal anemia, low birthweight and other pregnancy-related complications responsible for maternal and neonatal mortality. However, use of iron-folic acid supplements and adherence with recommended dosage in Nigeria is low. The purpose of this cross-sectional study was to examine factors associated with iron-folic acid supplements use among pregnant women in Karu local government area (LGA), Nasarawa, Nigeria.
methodsQuestionnaires were administered in face-to-face interviews with 64 pregnant women (aged 18-49 years) and 19 healthcare providers in selected public primary health facilities across Karu LGA, Nasarawa State. Using the theory of planned behavior, pregnant women's intention to use iron-folic acid supplements during pregnancy was predicted. In addition, factors associated with adherence to duration of use were also examined. Multiple linear regression was performed to examine the effect of attitudes, subjective norms and perceived behavioral control on intention to use, and binary logistic regression was used to examine factors associated with adherence to duration of use. Data was analyzed using STATA 15.0.
resultsAlmost all participants (97%) reported using iron-folic acid supplements, and 54% reported using iron-folic acid supplements daily. Subjective norm (p < 0.05) and perceived behavioral control (p < 0.05) significantly predicted intention to use iron-folic acid supplements during pregnancy. However, attitude did not have a predictive influence on intention. Also, pregnant women made an average of 2.7 antenatal care visits (standard deviation (SD) = 1.6), with most women (59%) having their first antenatal care visit within the second trimester (4-6 months) of pregnancy. Only one out of five attended within the first trimester (1-3 months). Overall, for every additional antenatal care visit, there was a significant increase in the likelihood of taking iron-folic acid supplements for three months or more (p < 0.05).
conclusionsThis study showed that perceived behavioral control and subjective norm were predictors of intention to use iron-folic acid supplements. Frequency of antenatal care visits was significantly associated with adherence to duration of iron-folic acid supplement use. Antenatal care attendance is very critical to the use of iron-folic acid supplements and should be promoted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.